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Asymmetricmetal catalysis has been regarded as one of themost
powerful tools for the preparation of stereochemically pure chiral
organic molecules.1 Over the last few decades, a myriad of chiral
metal complexes have been elaborated, paving the way for the
development of various catalytic asymmetric transformations.2 A
chiral metal catalyst generally comprises a central metal atom and
a chiral ligand, and its reactivity and selectivity are heavily depen-
dent on the ligand attributes. Despite the deep insight gained into
manifold reaction mechanisms and the advancement in theoretical
chemistry, however, rational design of chiral ligands that can attainsufﬁcient levels of catalytic efﬁciency and stereoselectivity in a tar-
get transformation remains very difﬁcult. Therefore, a process for
the discovery of an effective chiral ligand for a given asymmetric
reaction still involves numerous trial-and-error attempts.
Conventional chiral ligands rely on a covalently constructed,
single chiral molecule embedded with coordinative functional
groups. Their syntheses from each single molecule with the requi-
site chirality often require multi-step operation and can be compli-
cated. This intrinsic problem hinders the iterative design,
evaluation, and structural optimization processes in the identiﬁca-
tion of an optimal ligand. Thus, an alternative strategy that allows
the simple and rapid preparation of structurally diverse chiral
ligands would be of signiﬁcant importance.
Meanwhile, nature has evolved a wide variety of enzymes from
a relatively small number of building blocks, and a multitude of
conventional chiral ligand
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Figure 1. Three strategies toward the development of supramolecular chiral
ligands.
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asymmetric catalysis.3,4 Inspired by such a biological system,
supramolecular chiral ligands, which are assembled from small
molecules through non-covalent interactions and behave as sin-
gle-molecule chiral ligands, have recently attracted increasing
attention. These supramolecular chiral ligands have several advan-
tages over the conventional counterparts: (i) the synthesis of each
small component is in principle much easier than that of the more
complex conventional chiral ligands, (ii) the diverse combinations
of ligand components enable facile and rapid access to sufﬁciently
large libraries, (iii) the steric and electronic properties of the
ligands can be tuned easily by changing each component, and
(iv) the screening of the ligands can be considerably streamlined
through combinatorial methods.5–7
Several reviews have recently been published, covering various
topics related to supramolecular catalysis.8,9 In the present digest,
we will focus on selected reports on the three approaches to
supramolecular chiral ligands (Fig. 1). The ﬁrst approach is the
generation of self-assembled bidentate ligands from two mon-
odentate ligand components (Fig. 1a). The second is based on the
assembly of chiral ligands with achiral building blocks to construct
ligands that are more structurally complex (Fig. 1b). The third uti-
lizes the association of achiral ligands with chiral subcomponents
(Fig. 1c). Within the scope deﬁned above, the design principles
and synthetic applications of supramolecular chiral ligands are
described.
Supramolecular bidentate chiral ligands by assembly of two
monodentate ligands (Fig. 1a)
In the 1970’s, chelating bidentate chiral ligands were found to
be effective for asymmetric hydrogenation,10 and a variety of cata-
lysts bearing bidentate chiral ligands have been developed.11 The
preparation of bidentate chiral ligands through the supramolecular
assembly of monodentate ligands is an attractive strategy for read-
ily generating efﬁcacious chiral ligands. The ﬁrst example of such a
supramolecular bidentate chiral ligand was introduced by Reek
and co-workers.12 Their system featured the assembly of two mon-
odentate ligands 1 with bisporphyrin template 2b through the
coordinative interaction between the pyridine nitrogen of 1 and
the zinc center of each porphyrin ring in 2b (Scheme 1).13
Compared to the corresponding monodentate congener, which
was a complex generated from monodentate ligand 1, porphyrin
2a, and Rh(acac)(CO)2, supramolecular catalyst 3 exhibited higher
enantioselectivity in the hydroformylation of styrene (Scheme 2).
Although C2-symmetric chiral ligands have proven effective in a
wide range of metal-catalyzed asymmetric transformations, there
have been reactions that are promoted with higher efﬁciency and
stereocontrol by the catalysts bearing non-symmetric ligands
rather than C2-symmetric ones.11 One of the distinct advantagesof supramolecular bidentate ligands is the facile preparation of
non-symmetric chiral ligands from two different ligand compo-
nents. Reek and co-workers applied the zinc porphyrin–pyridine
coordination system to the design of non-symmetric supramolecu-
lar ligands.14 They developed porphyrin-functionalized chiral
phosphite ligands and nitrogen-containing phosphine ligands.
The simple mixing of these two ligand components with rhodium
salt in solution led to the spontaneous formation of a complex with
a non-symmetric chiral ligand via self-assembly of the comple-
mentary functionalities of each component (Fig. 2). This type of
supramolecular chiral ligand is suitable for the rapid preparation
of diverse catalyst libraries. For instance, a library of 48 bidentate
ligands can be generated from 4 porphyrin phosphites and 12
nitrogen-containing phosphines. The power of this strategy was
demonstrated by achieving the rhodium-catalyzed, highly enan-
tioselective hydrogenation of cyclic enamide 5 through the high-
throughput screening of the ligand library (Scheme 3).15
Another example of a non-symmetric supramolecular bidentate
ligand that harnessed zinc–nitrogen interaction was independently
reported by Takacs et al., who utilized a chiral bisoxazoline (box)
framework and Zn(II) metal for the ligand assembly.16 Mixing a
racemic mixture of box ligand 7 with Zn(OAc)2 resulted in the
preferential formation of heteroleptic complex (SS,RR)-8;
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observed (Scheme 4). Based on this observation, they developed
novel non-symmetric chiral ligands of type 9 consisting of two chi-
ral phosphites with the pendent box subunits (Fig. 3). This strategy
also suited for the preparation of a combinatorial ligand library,
and the screening of the chiral ligands enabled the highly enan-
tioselective hydroboration of alkenes and the asymmetric hydro-
genation of amino acid precursors.17
In addition tometal-heteroatom coordination, hydrogen-bonding
interaction has been exploited in the assembly of supramolecular
ligands. Breit and co-workers reporteda self-assembly strategybased
on complementary hydrogen bonding similar to that found in an A–T
base pair analog, which afforded structurally deﬁned non-symmetric
bidentate ligands.18 For instance, aminopyridine and isoquinolone
possessing chiral phosphorus ligand moieties, upon treatment with
ametal salt, generatedanewclass of heterobidentate supramolecular
chiral complexes10 (Scheme5). This systemwas successfully applied
to rhodium-catalyzedasymmetrichydrogenationandpalladium-cat-
alyzed asymmetric allylic amination.19
Based on the exclusive formation of heterobidentate
supramolecular complexes 10, Breit and co-workers subsequently
developed an efﬁcient method for combinatorial high-throughput
screening of catalyst libraries. For the rhodium-catalyzed asym-
metric hydrogenation, the iterative deconvolution strategy allowed
them to identify the optimal catalyst from a library of 120 hetero-
bidentate combinations within 17 experiments.20 The classical
individual examination of all 120 self-assembled catalysts con-
ﬁrmed that the catalyst identiﬁed through the iterative deconvolu-
tion process was indeed the best of the 120 catalysts. By using this
method, highly selective rhodium catalysts could be found for the
asymmetric hydrogenation of several alkene substrates (Scheme 6)
and the number of experiments required to identify the optimal
catalyst was dramatically reduced.N
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Figure 3. Self-assembled non-symmetric chiral diphosphate 9.Other families of chiral ligands based on the judicious use of
hydrogen-bonding donor/acceptor functionalities, such as pep-
tides,21 ureas,22 amides,23 sulfonamides,24 and phosphoramidites,25
were also developed. Furthermore, other types of non-covalent
interactions, such as acid-base interactions26 or cation-crown ether
complexations,27 were found to be suitable for the preparation of
self-assembled ligands. These approaches signiﬁcantly contributed
to the successful application of supramolecular bidentate chiral
ligands toward highly efﬁcient and enantioselective hydrogenation
with a broad substrate scope.
Assembly of chiral ligands with achiral building blocks (Fig. 1b)
The structural modiﬁcation of privileged chiral ligands, espe-
cially through the introduction of various substituents, represents
one of the most commonly employed yet reliable tactics for the
development of metal-catalyzed asymmetric transformations. For
example, the 2,20-disubstituted 1,10-binaphthyl skeleton has been
extensively explored as a key structure in chiral catalysts, and the
introduction and modiﬁcation of substituents at the 3,30-positions
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structural modiﬁcation entails time-consuming multi-step synthe-
ses. This problem can be circumvented through the supramolecular
strategy as it provides a new opportunity to modify the privileged
ligand structures in a facile manner,28 thus making it possible to
enhance the catalytic performance of the correspondingmetal com-
plexes within a short time frame.
Reek and co-workers applied the heteroatom-zinc(II) porphyrin
coordination to the modiﬁcation of octahydrobinaphthol-derived
chiral phosphoramidites. The self-assembly of 3,30-pyridyl sub-
stituents on the chiral biaryl core and zinc porphyrins created
the sterically congested environment around the P–N coordination
sites (Scheme 7).29 The potential utility of this approach was well
demonstrated in the rhodium-catalyzed regio- and enantioselec-
tive hydroformylation of unfunctionalized internal alkenes.
A similar yet different strategy for the preparation of
supramolecular Lewis acid complexes was introduced by Ishihara
and co-workers. They prepared 1,10-bi-2-naphthol (BINOL)-derived
supramolecular borate complex 13 from 3,30-bis(5,5-dimethyl-2-
oxido-1,3,2-dioxaphosphorinan-2-yl)-BINOL 14, 3,5-bis(triﬂuo-
romethyl)phenylboronic acid 15, and tris(pentaﬂuorophenyl)b
orane 16 (Scheme 8).30 Intermolecular Lewis acid-base coordina-
tion between the two P = O  B(C6F5)3 moieties was critical for theMe CHO
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Scheme 9. Anomalous endo-selective asymmetric Diels–Alder reaction.formation of the conformationally ﬂexible supramolecular com-
plex. Borane 16 acted as a bulky functional group to form a narrow
and deep cavity around the central boron atom. Moreover, the
strong electron-accepting nature of 16 increased the Lewis acidity
of the boron atom through the conjugated bonds, thus taking
advantage of Lewis acid-assisted chiral Lewis acid (LLA) catalysts.31
With supramolecular complex 13, they accomplished highly
enantioselective Diels–Alder reactions with anomalous endo/exo
selectivities (Scheme 9).
Achiral ligands with chiral subcomponents (Fig. 1c)
The underlying idea in the design of supramolecular chiral
ligands is to divide the structurally complex chiral ligands into
simpler components, and the way of dividing them largely deﬁnes
the characteristics of the respective design principles. In this
regard, a new approach based on the division of chiral ligands into
achiral ligands and chiral subcomponents has recently been intro-
duced. This is useful, especially for the preparation of phosphine
ligands, because the easily oxidizable nature of phosphines gener-
ally makes their syntheses labor-intensive. In addition, simpli-
ﬁcation of the phosphine structure itself and its modiﬁcation
with the aid of readily available chiral molecules would allow
the rapid and systematic preparation of structurally diverse arrays
of supramolecular ligands, thereby signiﬁcantly facilitating the dis-
covery of effective catalysts.
The feasibility of this idea was demonstrated by the Reek group.
Upon combining an achiral phosphine ligand bearing a pyridine
moiety with a chiral Zn(II) porphyrin (Fig. 4), they observed asym-
metric induction in the palladium-catalyzed allylic alkylation of
1,3-diphenylallyl acetate with dimethyl malonate, albeit with an
insufﬁcient level (up to 10% ee).28
Reek and co-workers subsequently reported the utilization of an
achiral diphosphine ligand that binds with carboxylate-containing
chiral molecules (Fig. 5).32 NMR experiments showed that, upon
binding of the chiral molecules in the pocket of the free diphos-
phine ligand, the phosphorus atoms and the indole and amide
NHs of the ligand became diastereotopic, conﬁrming that chiroge-
nesis was induced by chirality transfer from the carboxylate to
the ligand through supramolecular interactions. The screening of
many different chiral carboxylate derivatives revealed complexes
that could promote the asymmetric hydrogenation of a variety of
alkenes with excellent enantioselectivities (Scheme 10). They alsoFigure 4. Achiral pyridyl based phosphine ligand with chiral Zn(II) porphyrin.
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tiﬁcation of the optimal catalyst. The library of 24 chiral carboxy-
lates was divided into two subgroups, and was subjected to
asymmetric hydrogenation to identify the superior subgroup. By
following the superior set of carboxylates and further dividing them
into two smaller subgroups, the best chiral carboxylate was identi-
ﬁed through 9 experiments instead of 24.
From a similar standpoint, van Leeuwen et al. developed
supramolecular chiral ligand 17, which was assembled from an
achiral ligand and a chiral diol–titanium complex (Scheme 11).33
The Schiff base-phosphine hybrid ligands were treated with vari-
ous chiral diols in the presence of Ti(OiPr)4 to generate a library
of chiral bidentate ligands. The synthetic value of this library was
assessed in the rhodium-catalyzed asymmetric hydrogenation of
oleﬁns, and high enantioselectivities were obtained through the
appropriate choice of phosphine and diol.
The electrostatic interaction between positively and negatively
charged ions also offers a unique means for the design of
supramolecular chiral ligands. In conjunction with our researchTi(O iPr)4
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Scheme 12. Preparation of ion-paired chiral ligands.on organic ion-pair catalysis, we developed novel ligands assem-
bled through the ion-pairing between readily preparable achiral
phosphines incorporating ammonium ion moieties and chiral
anions. The simple two-step transformations starting from com-
mercially available benzylic amines can give rise to ammonium
phosphines 18. The subsequent ion-exchange process with BINOL
derivatives furnished supramolecular chiral ligands 19, termed
ion-paired chiral ligands (Scheme 12).34 The vast potential of this
new class of chiral ligands was clearly demonstrated through the
difﬁcult-to-control palladium-catalyzed asymmetric allylations of
prochiral carbon nucleophiles. In particular, excellent enantiose-
lectivity was attained in the allylic alkylation of a wide range of
a-nitrocarboxylates by taking advantage of the structural modu-
larity of the ion-paired ligands (Scheme 13).
The ion-paired ligand served as a powerful tool for developing
hitherto difﬁcult asymmetric bond-forming reactions by fully
exploiting a multitude of combinations of ammonium-phosphines
and easily accessible chiral anions. For instance, the employment
of appropriate chiral ligand 20 featuring a BINOL-derived chiral
phosphate ion35,36 allowed us to successfully develop an unprece-
dented highly E-selective and enantioselective allylation of 3-sub-
stituted benzofuran-2(3H)-ones with 1,2-disubstituted allylic
carbonates (Scheme 14).37 The origin of the high E-selectivity couldS
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Scheme 15. Iterative deconvolution screening for asymmetric allylation of
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2048 K. Ohmatsu, T. Ooi / Tetrahedron Letters 56 (2015) 2043–2048be ascribed to the ability of ion-paired ligand 20 to control either
the distribution of syn and anti p-allyl palladium complexes or
the relative rate of their bond formations.
Our group subsequently established a method for the in situ
generation of ion-paired chiral ligands from hydrogen sulfate salts
of ammonium phosphines and chiral Brønsted acids under phase-
transfer conditions. This technique was effectively utilized for the
iterative deconvolution screening of ion-paired chiral ligands in
asymmetric palladium catalysis. After only 16 experiments, the
best of 144 ligands could be identiﬁed to achieve the ﬁrst highly
enantioselective allylation of benzothiophenones (Scheme 15).38
Conclusions
Although miscellaneous chiral supramolecular ligands have
been developed, it would be fair to state that this ﬁeld is still in
its infancy and there remains much room for further development.
First, the synthesis of each component for self-assembly is rather
difﬁcult in many cases. Second, the search for non-covalent inter-
actions suitable for creating supramolecular chiral ligands is an
important task. Finally, most of supramolecular strategies are
applied toward well-established asymmetric transformations, such
as asymmetric hydrogenation of alkenes. Therefore, using self-
assembled chiral ligands to challenge hitherto difﬁcult asymmetric
bond-forming reactions is essential to expand the frontiers of
supramolecular catalysis.
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